Searched for
CAUTIONARY STATEMENT
When IPOs go wrong: SpaceX, AI firms face a delicate processAs SpaceX, Anthropic, and OpenAI eye massive IPOs, their leaders face Wall Street's scrutiny. Past market debuts offer cautionary tales, fr...
Quote of the day by Robert De Niro: ‘Better to be king for a night than a…’ – Iconic dialogue from ‘The King of Comedy’Robert De Niro's iconic line from 'The King of Comedy' explores the potent desire for recognition, suggesting a fleeting moment of fame is ...
Amazon aims to revolutionize fast delivery with new 30-minute systemAmazon is revealing a new service offering deliveries in 30 minutes or less for an additional charge. This ultrafast delivery, called Amazo...
The Buffett framework of investing: Why some stocks deserve a PE of 25, and others deserve a PE of 10In his letter to shareholders, Warren Buffett revealed a valuation framework that explained why stocks can lose half their value without an...
NSE warns investors against fraudulent activities by an unregistered entityThe National Stock Exchange (NSE) on Thursday warned investors regarding fraudulent activities perpetrated by an entity, Lazard Asset Manag...
Sebi issues cautionary statement, passes directions to protect investors from unregistered entitiesSebi (Investment Advisers) norms specify the eligibility conditions for registration, obligations and responsibilities and procedure for ac...
Mid- & small-caps still at full-to-lofty valuations: Kotak Institutional Equities"We are not sure if the correction marks a reversal of the market to fundamentals and numbers from sentiment and narratives," said Kotak's ...
NSE warns investors against entities running dabba trading activitiesThe National Stock Exchange (NSE) has warned investors against dabba trading, an illegal form of equity trading promoted by four individual...
NSE warns investors against illegal 'dabba' tradingThese persons were registered with a trading member (TM) as an authorised person (AP) and the said association as an AP was subsequently ca...
NSE cautions investors against 'dabba' tradingThe exchange said that these persons are not registered either as a member or authorised persons of any registered member of the NSE. Moreo...
NSE alerts investors against guaranteed returns investment plansThe cautionary statement comes after the NSE noticed that Sameer Gulabrao Thite associated with Samsan Unitrade was offering the service to...
NSE cautions investors against assured return productsEarlier, the exchange had issued similar advisories after information surfaced that entities like Real Trader and Groww Stock operating thr...
NSE cautious investors against guaranteed return products"Investors are cautioned and advised not to subscribe to any scheme/ product offered by any entities offering indicative/assured/guaranteed...
- SC seeks explanation from UP on its plans to hold Kanwar Yatra
A bench of Justices RF Nariman and BR Gavai asked the state government to explain its position by Friday. Uttarakhand has already decided t...
HMSI recalls 50,034 units of four models to rectify front-brake componentUnder the recall campaign, a total of 50,034 units of these models will be attended, HMSI said in a statement.
RBI slaps Rs 3 crore penalty on Citibank IndiaThe penalty was based on shortcomings in regulatory compliance and does not question the validity of any transaction the bank entered with ...
'Suno RBI Kya Kehta Hai' campaign against fake offers soonThe drive comes amid rising instances of fraudsters trying to dupe gullible customers by promising them lucrative financial gains and prize...
Resolved the matter with Ranbaxy: Apollo PharmacyApollo Pharmacy today said it has resolved the matter and will continue to sell Ranbaxy's medicines from its outlets across the country.
Apollo Pharmacy reviewing quality of Ranbaxy drugs"We haven't suspended the drugs per se, but our medical oversight committee has asked for FDA and GMP certificate for medicines that we dis...
Cautionary advisory against Ranbaxy drugs, says Apollo PharmacyLeading pharmacy chain Apollo Pharmacy today said it has issued a "cautionary advisory" against drugs made by Ranbaxy Laboratories